[
  {
    "patient_id": "PAT_0001",
    "nct_id": "NCT06219590",
    "title": "Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy",
    "eligible": true,
    "reasons": [],
    "match_score": 0.582,
    "patient_summary": {
      "conditions": [
        "Type 1 Diabetes",
        "Neuropathy"
      ],
      "medications": [
        "Insulin"
      ]
    },
    "Criteria": {
      "inclusion": [
        "Patients have to be symptomatically stable with type 2 diabetes mellitus complicated with peripheral neuropathy.",
        "Optimized pharmacological treatment that will be remained unchanged throughout the study."
      ],
      "exclusion": [
        "Implanted cardiac pacemakers.",
        "Patients with known skin allergies.",
        "Presence of skin inflammations.",
        "Peripheral vascular disease."
      ]
    }
  },
  {
    "patient_id": "PAT_0001",
    "nct_id": "NCT06407297",
    "title": "UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes",
    "eligible": true,
    "reasons": [],
    "match_score": 0.5726,
    "patient_summary": {
      "conditions": [
        "Type 1 Diabetes",
        "Neuropathy"
      ],
      "medications": [
        "Insulin"
      ]
    },
    "Criteria": {
      "inclusion": [
        "Meets the diagnostic criteria for diabetes according to the World Health Organization (WHO) guidelines from 1999.",
        "Presence of at least one pancreatic autoantibody, or idiopathic type 1 diabetes mellitus (T1DM) with negative autoantibody testing.",
        "Ages 8 to 18 years, regardless of gender.",
        "Newly diagnosed T1DM within the past 6 months.",
        "Fasting C-peptide \u22650.1 nmol/L and postprandial 2-hour C-peptide >0.2 nmol/L.",
        "Voluntary acceptance of stem cell transplantation therapy by the individual, their family members, or legal guardians, and signing of an informed consent form."
      ],
      "exclusion": [
        "Diabetic ketoacidosis is not under control.",
        "Severe allergic constitution.",
        "BMI <14 or >35.",
        "History of other autoimmune diseases, hematologic disorders.",
        "HIV positive, carrier of viral hepatitis, active phase of viral hepatitis, or other uncontrolled infectious diseases.",
        "History of acute pancreatitis, pulmonary embolism, or other thrombotic diseases, as well as severe diseases of the heart, liver, kidneys, respiratory system, nervous system, etc.",
        "Suffering from gestational diabetes, monogenic diabetes, diabetes caused by pancreatic injury, or other secondary diabetes (such as Cushing's syndrome, thyroid dysfunction, or acromegaly-induced diabetes).",
        "Pregnancy or planning pregnancy within 3 months before or after treatment, as well as breastfeeding women.",
        "Mental illness, alcohol or drug abuse, inability to comply with treatment.",
        "Known or suspected tumors.",
        "According to the investigator's judgment, there are other clinical conditions that may endanger the safety of the subjects."
      ]
    }
  },
  {
    "patient_id": "PAT_0001",
    "nct_id": "NCT05498974",
    "title": "China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes",
    "eligible": true,
    "reasons": [],
    "match_score": 0.5675,
    "patient_summary": {
      "conditions": [
        "Type 1 Diabetes",
        "Neuropathy"
      ],
      "medications": [
        "Insulin"
      ]
    },
    "Criteria": {
      "inclusion": [
        "Patients with type 1 diabetes mellitus of any duration; meeting criteria (1) or any of (2) or any of (3)",
        "Clinical diagnosis of type 1 diabetes by a specialist",
        "Age at onset < 15 years; no overweight or obesity at onset; previous diabetic ketoacidosis; highest random C-peptide < 200 pmol/L",
        "Initiation and continuation of insulin therapy (except pancreatic or islet transplantation) after diagnosis; positive islet autoantibodies",
        "Children and adolescents with diabetes mellitus at age of onset <= 20 years, regardless of type and duration of disease."
      ],
      "exclusion": [
        "No insulin dependence for at least 6 months after diagnosis of diabetes mellitus.",
        "No DKA for 1 month off insulin for those with a history of diabetes > 1 year.",
        "C-peptide > 800 pmol/L at any time point."
      ]
    }
  },
  {
    "patient_id": "PAT_0001",
    "nct_id": "NCT07248631",
    "title": "Combined Effects of Foot-Ankle Therapeutic Exercises and Mindful Walking in Patients With Diabetic Polyneuropathy",
    "eligible": true,
    "reasons": [],
    "match_score": 0.5619,
    "patient_summary": {
      "conditions": [
        "Type 1 Diabetes",
        "Neuropathy"
      ],
      "medications": [
        "Insulin"
      ]
    },
    "Criteria": {
      "inclusion": [
        "Diagnosed with diabetic polyneuropathy (DPN) confirmed by medical history and clinical examination.",
        "Experience pain and disability in foot/ankle, with a Numeric Pain Rating Scale (NPRS) score \u2265 4.",
        "Independent walking ability for at least 10 m.",
        "Age (40-75) years.",
        "Ability to understand and follow exercise instructions.",
        "A maximum of one amputated toe, not being the hallux.",
        "Willingness to participate in the study and provide informed consent."
      ],
      "exclusion": [
        "Presence of an active plantar ulcer or gangrene.",
        "History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period.",
        "Arthroplasty and/or orthosis of lower limbs or indication of lower limb arthroplasty throughout the intervention period.",
        "Participating in other exercise programs or studies.",
        "Dementia or inability to give consistent information.",
        "Diagnosis of neurological diseases.",
        "Neuropathic pain due to other causes (e.g., HIV, chemotherapy).",
        "Major vascular complications and/or severe retinopathy."
      ]
    }
  },
  {
    "patient_id": "PAT_0001",
    "nct_id": "NCT07063524",
    "title": "Transcutaneous Electrical Stimulation and Controlled Heat in People With and Without Diabetes",
    "eligible": false,
    "reasons": [
      "Reasoning Engine Veto: Diagnosed neuropathy"
    ],
    "match_score": 0.5363,
    "patient_summary": {
      "conditions": [
        "Type 1 Diabetes",
        "Neuropathy"
      ],
      "medications": [
        "Insulin"
      ]
    },
    "Criteria": {
      "inclusion": [
        "Male or Female aged between 45-75 years old",
        "Clinical diagnosis of Type I or Type II diabetes",
        "Controlled diabetes mellitus (HbA1c \u2264 7%)"
      ],
      "exclusion": [
        "Pregnancy",
        "Current smoker",
        "Diagnosed neuropathy",
        "Uncontrolled hypertension (HTN)",
        "Allergy to tape or electrodes",
        "Diagnosis of dementia",
        "History of knee joint replacement",
        "Significant joint pain (e.g., back, hip, or ankle) that may limit the ability to wear a boot for 60 minutes",
        "Presence of pacemakers",
        "Dermatological conditions",
        "Abnormal sensation in the knees",
        "Chronic obstructive pulmonary disease",
        "Cardiovascular disease",
        "Arteriosclerosis obliterans",
        "Cerebrovascular accident",
        "Lumbar disc disorders (e.g., herniation)",
        "Rheumatoid arthritis",
        "Fear of electrical stimulation"
      ]
    }
  }
]